Get started
Biomerica, Inc.Biomerica, Inc.Biomerica, Inc.

Biomerica, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

BMRA trade ideas

BMRA Long / ride up but major resistance ahead BMRA, nice volumes and ride up possible to 4.1 around Beware ! Go monthly view, there is a MAJOR resistance at 4.8, the graph shows this threshold since the 80s Just in case you plan a take profit above 5, beware some major short might pop up before. As usual, those a just scenarii possible, this is not a recommendation to buy ! Any advise appreciated ! Please manage your risk and position sizing according to your plan. All the best !
NASDAQ:BMRALong
by PabloEsco1
Biomerica’s Covid-19 Antigen Rapid Test Receives CE MarkBiomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark Biomerica receives first orders and plans to ship tests in coming weeks Clinical studies demonstrated an overall performance of 94.7% positive agreement (sensitivity) and 99.7% negative agreement (specificity) as compared to lab-based molecular PCR tests The Company has already received its first European orders and plans to ship the first part of these orders in the coming weeks. The Company will now begin marketing this product broadly in Europe and other regions outside of the US. merica’s new COVID-19 Antigen Rapid Test is highly portable, affordable, and provides results in 15 minutes with no equipment required to perform or read the test. finance.yahoo.com
NASDAQ:BMRA
by AlenCiken
Biomerica, Inc. Bullish but extended Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.
NASDAQ:BMRA
by DEXWireNews
1
BMRA - RISKY BUT TREND IS STRONG PULLBACK COMINGBiomerica, Inc. is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company's medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians' offices and over-the-counter drugstores). The Company operates in Europe, the United States, Asia, South America, the Middle East and other foreign countries. The Company's diagnostic test kits are used to analyze blood, urine or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which exist in the human body in various concentrations. The Company primarily focuses on products for gastrointestinal (GI), food intolerances, diabetes and esoteric tests. The Company's diagnostic products use immunoassay technology. SHORT INTEREST 22.39K 07/15/19 P/E Current -19.53 P/E Ratio (with extraordinary items) -13.60 Average Recommendation: BUY Average Target Price: 6.25
NASDAQ:BMRALong
by DEXWireNews